Nicholas Landau Appointed to BIO Alabama Board of Directors

Press Release

Bradley is pleased to announce that Nicholas J. Landau, Ph.D., a partner in the firm’s Birmingham office, has been appointed to the board of directors of BIO Alabama for 2018-19.

“We congratulate Nick on his appointment to the BIO Alabama board and we look forward to his leadership in helping to grow biotechnology innovation in Alabama,” said Bradley Birmingham Office Managing Partner Dawn Helms Sharff.

BIO Alabama represents Alabama's bio related industries, research scientists, clinicians and business professionals who are working together to foster, develop and support the life sciences in Alabama. BIO Alabama is the state affiliate in Alabama of the Biotechnology Innovation Organization (BIO), the preeminent national association for biotechnology companies.

A member of Bradley’s and Life Sciences Industry Team and Intellectual Property and Litigation practice groups, Dr. Landau advises clients in the procurement, protection and litigation of all forms of intellectual property, including patents, trademarks and trade secrets. He is particularly experienced in patent prosecution, having drafted more than 150 patent applications in numerous areas of technology. He has worked with patents in a broad array of technological disciplines and has extensive knowledge in the areas of biotechnology, pharmaceuticals, nutraceuticals, medical devices and environmental technology. His clients include individuals, universities, startups, growing businesses, and publicly traded companies.

Dr. Landau also is an adjunct professor at the Cumberland School of Law at Samford University and coordinates the Pro Bono Patent Program for the states of Alabama and Mississippi.